Opening November 2024
This state-of-the-art facility will feature advanced Molecular imaging encompassing PET-CT and SPECT-CT.
PET-CT is an essential tool in the diagnosis and management of many cancers including melanoma, lung cancer, lymphomas, breast, colon and prostate cancer.
SPECT-CT plays an enormous role in functional imaging of various organs such as the heart, bones and thyroid.
In addition, the new purpose-built clinic will provide a personalised treatment service (Theranostics) for a variety of treatments including prostate and neuroendocrine cancers.